CARDINAL HEALTH INC 4
4 · CARDINAL HEALTH INC · Filed May 15, 2017
Insider Transaction Report
Form 4
Giacomin Jon L
CEO, Pharmaceutical Segment
Transactions
- Exercise/Conversion
Common Shares
2017-05-12$41.60/sh+23,270$968,032→ 55,440 total - Sale
Common Shares
2017-05-12$72.87/sh−23,270$1,695,685→ 32,170 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-05-12$41.60/sh−23,270$968,032→ 0 totalExercise: $41.60Exp: 2021-08-15→ Common Shares (23,270 underlying)
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.81 to $72.91, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
- [F2]The option, representing a right to purchase a total of 23,270 shares, vested and became exercisable in three equal annual installments beginning on August 15, 2012.